$KNC/BTC 3D (#BinanceSpot) Descending trendline break & retest
Updated
Kyber Network Crystal has regained 50MA support and seems ready for big recovery!
kyber.network
Current Price= 0.00003188
Buy Entry= 0.00003192 - 0.00002850
Take Profit= 0.00004287 | 0.00005888 | 0.00008499
Stop Loss= 0.00002387
Risk/Reward= 1:2 | 1:4.52 | 1:8.64
Expected Profit= +41.91% | +94.90% | +181.33%
Possible Loss= -20.99%
Fib. Retracement= 0.5 | 0.786 | 1.117
Margin Leverage= 1x
Estimated Gain-time= 9 months
Contracts:
#ERC20 0xdeFA4e8a7bcBA345F687a2f1456F5Edd9CE97202
#BEP20 0xfe56d5892bdffc7bf58f2e84be1b2c32d21c308b
#Polygon 0x1c954e8fe737f99f68fa1ccda3e51ebdb291948c
kyber.network
Current Price= 0.00003188
Buy Entry= 0.00003192 - 0.00002850
Take Profit= 0.00004287 | 0.00005888 | 0.00008499
Stop Loss= 0.00002387
Risk/Reward= 1:2 | 1:4.52 | 1:8.64
Expected Profit= +41.91% | +94.90% | +181.33%
Possible Loss= -20.99%
Fib. Retracement= 0.5 | 0.786 | 1.117
Margin Leverage= 1x
Estimated Gain-time= 9 months
Contracts:
#ERC20 0xdeFA4e8a7bcBA345F687a2f1456F5Edd9CE97202
#BEP20 0xfe56d5892bdffc7bf58f2e84be1b2c32d21c308b
#Polygon 0x1c954e8fe737f99f68fa1ccda3e51ebdb291948c
Trade active
1st entry filledKyber Network Crystal precisely bounced on demand zone but got rejected on 100EMA resistance, next attempt would be enough to break it!
Trade closed: target reached
TP1 reached with +39.41% and +2RKyberNetworkCrystal confirmed the breakout and pumped while market is still bleeding, such an outsider!
Bullish continuation is in play, SL adjusted to lowest entry now (0.00002850).
Trade closed: target reached
TP2 reached with +87.95% and +4.52RKyber Network Crystal continued bullish and was not distracted by the rest of the market.
Just got rejected on 200MA resistance, SL adjusted to highest entry now (0.00003192)
Trade closed: target reached
TP3 reached with +174.80% and +8.64R🎯Kyber Network Crystal regained 200MA and went for final target after missing it by a few sats.
It may seem it took a while but actually it was faster than expected, HTF set-ups are for extra patient traders.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.